According to in silico analyses of data from the TCGA database, numerous components of the PI3K-AKT-mTOR pathway were upregulated more frequently than any other pathway in cancer by mutation, loss, DNA methylation, amplification and translocation, with resultant activation of the pathway [13, 14]. This evidence concerns the gene AKT1 and cancer.